Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry

Br J Dermatol. 2017 Dec;177(6):e325-e326. doi: 10.1111/bjd.15659. Epub 2017 Nov 22.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Infliximab / therapeutic use*
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Registries
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals
  • CT-P13
  • Dermatologic Agents
  • Infliximab